Disease & disorder

gastroesophageal reflux disease

MONDO:0007186

A chronic disorder characterized by reflux of the gastric and/or duodenal contents into the distal esophagus. It is usually caused by incompetence of the lower esophageal sphincter. Symptoms include heartburn and acid indigestion. It may cause injury to the esophageal mucosa.

Clinical trials72
Recruiting4
Drug concepts studied9
Synonyms6

Disease research snapshot

CureCurrent currently links 72 distinct registered clinical trials to gastroesophageal reflux disease through its MONDO disease mappings. 4 of those studies have the registry status “recruiting” (6%). These are registry statuses, not availability guarantees, study results or evidence of effectiveness.

The leading sponsor shown in this linked dataset is Clinica Gastrobese, associated with 4 distinct linked trials. This is a count of records, not a ranking of the sponsor's scientific quality.

The highest-count mapped research city in the current result is Kansas City, United States. Only site locations available in the published registry projection are counted; some trial sites may be missing or outdated.

The most frequently mapped drug concept in the current linked trials is pantoprazole (4 distinct trials). This describes what has been studied, not a recommended treatment.

Numbers are derived from CureCurrent's current ClinicalTrials.gov projection and conservative MONDO/RxNorm mappings. See sources, counting rules and limitations and verify eligibility or clinical findings with the original study record.

Research intelligence

Directly mapped studies only · unique clinical trials

Current registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.

Medications under investigation

Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.

Loading mapped interventions…

MONDO disease family

Loading verified ontology relationships…

Recruiting studies by city

Loading research-site locations…

Trial status

Loading…

Trial phase

Loading…

Study start year

Loading…

Investigated drug interventions

Loading…
Background context

Gastroesophageal reflux disease

Gastroesophageal reflux disease (GERD) or gastro-oesophageal reflux disease (GORD) is a chronic upper gastrointestinal disease in which stomach content persistently and regularly flows up into the esophagus, resulting in symptoms and/or complications. Symptoms include dental corrosion, dysphagia, heartburn, odynophagia, regurgitation, non-cardiac chest pain, extraesophageal symptoms such as chronic cough, hoarseness, reflux-induced laryngitis, or asthma. In the long term, and when not treated, complications such as esophagitis, esophageal stricture, and Barrett's esophagus may arise. Risk factors include obesity, pregnancy, smoking, hiatal hernia, and taking certain medications. Medications that may cause or worsen the disease include benzodiazepines, calcium channel blockers, tricyclic antidepressants, NSAIDs, and certain asthma medicines. Acid reflux is due to poor closure of the lower esophageal sphincter, which is at the junction between the stomach and the esophagus. Diagnosis among those who do not improve with simpler measures may involve gastroscopy, upper GI series, esophageal pH monitoring, or esophageal manometry. Treatment options include lifestyle changes, medications, and sometimes surgery for those who do not improve with the first two measures. Lifestyle changes include not lying down for three hours after eating, lying down on the left side, raising the pillow or bedhead height, losing weight, and stopping smoking. Foods that may precipitate GERD symptoms include coffee, alcohol, chocolate, fatty foods, acidic foods, and spicy foods. Medications include...

Background only. Canonical identity remains MONDO; clinical-trial relationships come from ClinicalTrials.gov.

Clinical trials

40 shown
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)NCT06783751 · 2025-03-21
RECRUITING
Endoscopic Conversion of Sleeve Gastrectomy to Single Anastomosis Sleeve-ileal Bypass (SASI) for Gastroesophageal Reflux (GERD), Primary and Secondary Non-responder.NCT06757296 · 2025-02-03
RECRUITING
Crural Repair During Laparoscopic Sleeve Gastrectomy in Patients With a Lax Gastroesophageal JunctionNCT05330910 · 2022-04-01
RECRUITING
Functional Changes in the Stomach and Esophagus After One Anastomosis Gastric Bypass- OAGBNCT04422405 · 2020-06-01
RECRUITING
De Novo Gastroesophageal Reflux Disease After Sleeve Gastrectomy With and Without OmentopexyNCT07854613 · 2026-10-15
NOT_YET_RECRUITING
Effect of Omeprazole on Gut Microbiota in Adults With Obesity and GERDNCT07850960 · 2026-09-25
NOT_YET_RECRUITING
Reflux Disease After Gastric Bypass Versus Sleeve Gastrectomy in Morbid Obese Patients: an Italian StudyNCT04763993 · 2026-05-01
NOT_YET_RECRUITING
Effect of Laparoscopic Sleeve Gastrectomy Versus Roux-en-Y Gastric Bypass on Gastroesophageal Reflux Disease: An 8-Year Prospective Cohort StudyNCT03692455 · 2025-09-17
ENROLLING_BY_INVITATION
Mandatory Hiatoplasty in Sleeve Gastrectomy for Gastro-Esophageal Reflux DiseaseNCT06316167 · 2024-03-01
UNKNOWN
Biological Sample Repository for Gastrointestinal DisordersNCT05874726 · 2023-07-19
ACTIVE_NOT_RECRUITING
Impact of GEA Simultaneous to VSG on Post-operative GERDNCT07537244 · 2023-02-18
ACTIVE_NOT_RECRUITING
Ultrasound Assessment for Comparison of Gastric Residual Volume After Ingestion of Carbohydrate Drink and Water in Obesity Class II and III Volunteers at Risk of AspirationNCT06941623 · 2023-02-01
COMPLETED
Development of Machine Learning Models for the Prediction of BMI and Complications After Bariatric Surgery (CABS-Study)NCT05710913 · 2023-01-05
UNKNOWN
Systems Biology of Gastrointestinal and Related DiseasesNCT05579444 · 2022-11-11
TERMINATED
Impact of Crural Repair and Gastropexy During Laparoscopic Sleeve GastrectomyNCT07560787 · 2022-11-01
COMPLETED
Sleeve Gastrectomy With Cruroplasty and Omental Rape for Treatment of Morbid Obesity With Reflux DiseaseNCT05590208 · 2022-10-12
COMPLETED
Comparison of the Sleeve Gastrectomy Technique With a Nissen Fundoplication Added to the Conventional Sleeve Gastrectomy Technique in Morbidly Obese PatientsNCT04626232 · 2022-09-12
TERMINATED
Gastroesophageal Reflux Disease After Laparoscopic Sleeve GastrectomyNCT05486169 · 2022-09-01
COMPLETED
Sleeve Gastrectomy With Reestablishment of the Acute Angle of His (SG-REACH) in Obese PatientsNCT05452980 · 2022-06-01
UNKNOWN
Non-endoscopic Esophageal Sampling to Detect Barrett's Esophagus and Esophageal Cancer in VeteransNCT05210049 · 2022-03-01
UNKNOWN
Determination of Change in Reflux Disease After Sleeve Gastrectomy by Intraluminal Impedance and pH-meterNCT05405816 · 2022-01-01
COMPLETED
Acoustic Cough Monitoring for the Management of Patients With Known Respiratory DiseaseNCT05042063 · 2021-09-15
COMPLETED
Nissen Sleeve by Single Port With Magnetic AssistanceNCT04931706 · 2021-06-05
UNKNOWN
Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2NCT04846010 · 2021-03-01
UNKNOWN
GERD After Sleeve GastrectomyNCT05178446 · 2021-01-01
COMPLETED
MCT and Capsaicin Provocation Challenge in Diagnosis of Chronic CoughNCT03363698 · 2020-12-31
COMPLETED
Endoscopy-related Phone Consultation During the COVID-19 OutbreakNCT04344964 · 2020-04-15
COMPLETED
A Study to Reduce the Reflux After a Sleeve Gastrectomy in Obese PatientsNCT04287972 · 2019-11-08
WITHDRAWN
Antireflux Efficacy of Hiatal Hernia Repairs in Sleeve Gastrectomy PatientsNCT04433507 · 2019-04-01
TERMINATED
Long Term Outcomes of Bariatric Patients Treated With Surgery or EndoscopyNCT03705416 · 2019-03-30
ACTIVE_NOT_RECRUITING
One Anastomosis Gastric Bypass With Excluded Stomach Fundoplication: FundoRing vs Nissen vs OAGB Without FundoplicationNCT04828733 · 2019-03-29
COMPLETED
Laparoscopic Sleeve Gastrectomy With or Without Hiatal Hernia Repair in Morbidly Obese PatientsNCT03776669 · 2019-01-09
UNKNOWN
Effect of Obesity on Proton Pump InhibitorsNCT04248335 · 2018-07-03
COMPLETED
The Detection of Barrett's Esophagus by Gastrointestinal Endoscopy Prevents Esophageal Carcinoma in Morbid Obese After Sleeve GastrectomyNCT03596411 · 2018-05-17
COMPLETED
Long-term Follow-up After OAGBNCT07125638 · 2018-01-01
COMPLETED
Genotype-tailored Treatment of Symptomatic Acid-Reflux in Children With Uncontrolled AsthmaNCT03015610 · 2017-10-31
COMPLETED
LINX Reflux Management System in Subjects With GERD Who Have Previously Undergone a Laparoscopic Sleeve GastrectomyNCT02429830 · 2017-04-05
COMPLETED
Prevalence, Predictors and Management of Gastroesophageal Reflux After Laparoscopic Sleeve GastrectomyNCT05416645 · 2017-01-01
COMPLETED
The Study of Nutrition of Children and Adolescents With GERDNCT04202276 · 2017-01-01
COMPLETED
Influence of Central Obesity on the Esophageal Epithelial BarrierNCT02776982 · 2016-11-01
COMPLETED

Leading sponsors

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.